Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04015544 · ClinicalTrials.gov registry record · NA
Markers of Atherosclerosis in Overweight, Postmenopausal Women Following Daily Watermelon Consumption
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT04015544 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 52 participants.
The verdict
NCT04015544, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the effectiveness of six weeks of watermelon puree supplementation, compared to control (no treatment), on blood antioxidant capacity, inflammation markers in the blood, biomarkers of metabolism in the blood, and cardiovascular disease markers in the blood, and biomarkers in the blood related to watermelon ingestion in overweight post-menopausal women. The secondary purpose is to compare body composition and body mass between the watermelon supplement group and the control group.
Interventions
- DIETARY_SUPPLEMENT Watermelon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04015544
The ClinicalTrials.gov registry entry for NCT04015544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Watermelon is the first listed.
NCT04015544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04015544 about?
NCT04015544 is a clinical study titled "Markers of Atherosclerosis in Overweight, Postmenopausal Women Following Daily Watermelon Consumption". The primary purpose of this study is to determine the effectiveness of six weeks of watermelon puree supplementation, compared to control (no treatment), on blood antioxidant capacity, inflammation markers in the blood, biomarkers of metabolism in the blood, and cardiovascular disease markers in the...
What is the current status of trial NCT04015544?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2014-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT04015544?
The interventions under investigation include: Watermelon (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04015544?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.